Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001598599-25-000008
Filing Date
2025-02-18
Accepted
2025-02-18 06:16:19
Documents
2
Period of Report
2025-02-17

Document Format Files

Seq Description Document Type Size
1 6-K a250217_6kincorporated-iphx.htm 6-K 16251
2 EX-99.1 exhibit991-250217.htm EX-99.1 23488
  Complete submission text file 0001598599-25-000008.txt   40911
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 25632575
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)